INTRODUCTION
In growing epithelia, information about growth, metabolic status, or genetic identity is shared locally among cells to establish themselves as relatively weaker or stronger. The sensing of differences in fitness results in competition for tissue occupancy and improves the proliferation potential of the more robust ''winner'' cells at the expense of the relatively less robust ''loser'' cells. This conserved homeostatic process, called cell competition, facilitates the health of growing tissues and aids in tissue size regulation (reviewed in Baker, 2011; Johnston, 2009 ). The best-characterized examples of cell competition occur between wild-type (WT) Drosophila cells and cells mutant for one of a number of ribosomal proteins (collectively called Minute, or M mutants), or between WT cells and cells expressing higher or lower amounts of Drosophila Myc (hereafter called Myc), the sole homolog of the c-Myc transcriptional regulator and oncoprotein. Indeed, primordial wing cells that differ less than 2-fold in Myc expression compete vigorously for occupancy of the adult wing (de la Cova et al., 2004; Johnston et al., 1999; Moreno and Basler, 2004) . Evidence indicates that intercellular signaling mediates competitive behavior. Winner cells transmit a killing signal to loser cells, which die by apoptosis, and loser cell participation promotes expansion of the winner cells (de la Cova et al., 2004; Rhiner et al., 2010; Senoo-Matsuda and Johnston, 2007) . Cell competition is thought to be an evolutionarily conserved mechanism of ensuring optimal organ fitness, via recognition and elimination of cells deemed dangerous to the animal (Johnston, 2013) . Recent reports suggest that a Myc-based cell fitness surveillance system operates at early mouse embryonic stages to optimize development (Clavería et al., 2013; Sancho et al., 2013) .
How cell fitness is mechanistically defined and how fitness differences are recognized remain unclear. Studies have identified genes expressed in loser cells (de la Cova et al., 2004; Portela et al., 2010; Rhiner et al., 2010) , but what defines winner cells has received little attention. Broadly, cell fitness is a cell's capacity to reproduce and populate a tissue. However, cell competition relies on relative differences in cell fitness, making winner fitness difficult to define: WT cells are winners when growing next to M/+ cells (Morata and Ripoll, 1975) or cells mutant for diminutive (dm), encoding Drosophila Myc (Johnston et al., 1999; Wu and Johnston, 2010) , or c-Myc (Clavería et al., 2013) , but are losers when next to cells with more Myc (Clavería et al., 2013; de la Cova et al., 2004; Moreno and Basler, 2004; Sancho et al., 2013) , more Yki, the transducer of the Hippo tumor suppressor pathway (Neto-Silva et al., 2010; Tyler et al., 2007; Ziosi et al., 2010) , or more Wnt/Wingless (Vincent et al., 2011) or JAK/STAT activity (Rodrigues et al., 2012) ; or with less p53 activity (Bondar and Medzhitov, 2010; Dejosez et al., 2013; Marusyk et al., 2010) . Cell fitness is thus under constant surveillance in growing tissues, and mechanisms exist to recognize disparities when they arise.
In Drosophila tissues, ectopic Myc expression drives cellular growth, but developmental constraints prevent acceleration of cell division; thus tissue mass is promoted by increasing cell size, not cell number (Johnston et al., 1999) . In cell culture, however, it stimulates both growth and division, leading to a faster proliferation rate (Senoo-Matsuda and Johnston, 2007) . In mosaic wing imaginal discs or in mixed cell populations in culture, interactions between WT and Myc-expressing cells cause Myc cells to acquire ''supercompetitor'' behavior that increases their reproductive fitness and enables them to overtake the tissue by killing off their WT neighbors. This behavior is analogous to cancer and suggests that cancer cells and supercompetitor cells may use similar mechanisms to surpass normal controls on tissue growth (Baker and Li, 2008; Johnston, 2013; Moreno, 2008) . Many of c-Myc's target genes regulate glucose metabolism, and its increased expression promotes aerobic glycolysis, known as the Warburg effect (Dang, 1999) . This metabolic switch is common in tumor cells and may facilitate their rapid expansion (Assaily and Benchimol, 2006; Young and Anderson, 2008) , and in combination with its potent growth-promoting properties makes Myc activity powerfully oncogenic. The discovery of Myc's supercompetitor capacity makes its role in tumor promotion potentially even more destructive.
We undertook these studies to probe the molecular basis of the fitness of Myc supercompetitor cells. Using a combination of in vivo and cell culture approaches, we confirm that simple increases in Myc expression reprogram metabolism in Drosophila, and we demonstrate that the tumor suppressor p53 is induced adaptively to regulate mitochondrial respiration. Strikingly, in competitive mosaics, p53 promotes considerable enhancement of metabolic flux in Myc cells in a distinct role. Here, p53 endows and protects supercompetitor behavior of Myc cells: in its absence, Myc supercompetitors no longer kill WT cells, cannot expand as a population, have increased genomic instability, and undergo catastrophic induction of apoptosis. Myc-expressing cells only require the protective role of p53 when in the presence of WT neighbor cells. We propose that p53 detects confrontation between Myc and WT cells and mediates a genetic program that elevates Myc cells to supercompetitor status. Our experiments demonstrate the determinative nature of cellular context and suggest a mechanism by which confrontation between emerging cancer cells and nearby WT cells may promote mammalian tumor formation by further boosting cell metabolism and fitness.
RESULTS

Myc Expression Stimulates Glycolysis but Impairs Oxidative Phosphorylation
Virtually nothing is known about the basis of the fitness advantage of Myc supercompetitor cells during cell competition, but Myc proteins have well-known roles in regulation of ribosome biogenesis and cellular metabolism. Stimulation of glucose uptake and conversion of pyruvate to lactate instead of acetyl Co-A for Krebs cycle utilization ( Figure 1A ) is a hallmark of cancer cells and is thought to promote increased proliferation (Hanahan and Weinberg, 2011 ); thus we asked if metabolic changes underlay Myc supercompetitive behavior. We found that in the absence of competition, a simple increase in Myc expression stimulates glycolysis by examining glucose metabolism in monocultures of Drosophila S2 cells stably transfected with a Cu-inducible Myc transgene (hereafter called Myc cells). While Cu induction on its own had little effect on metabolism (see Figure S1 available online), induction of Myc led to significant increases in expression of genes encoding glycolytic enzymes, including phosphoglucose isomerase (Pgi), phosphofructokinase (Pfk), triose phosphate isomerase (Tpi), the glucose transporter glut1, and impl3, encoding lactate dehydrogenase (Ldh) ( Figure 1B ). Glucose consumption was also increased in Cu-induced Myc cells, but not in uninduced Myc cells (data not shown) or control Cu-induced S2 (WT) cells ( Figure 1D ), which was accompanied by an increase in intracellular lactate ( Figure 1E ). Stimulation of glycolytic gene expression and flux by Myc is thus a conserved regulatory process. We also noted upregulation of genes encoding proteins functioning in mitochondria to promote oxidative respiration in Myc-expressing cells, including synthesis of cytochrome C oxidase (Scox), required for assembly of cytochrome c oxidase (COX, complex IV) (Yang et al., 2010) , succinate dehydrogenase (Sdh), a component of the electron transport chain (ETC; complex II), and pyruvate dehydrogenase (Pdh), which catalyzes decarboxylation of pyruvate and generates acetyl CoA for the Krebs cycle ( Figure 1C ). Despite increased expression of these genes, steady-state ATP in Myc cells was 30% lower than in WT cells ( Figure 1F ). Myc expression thus reconfigures cellular metabolism so that oxidative phosphorylation is displaced as the predominant source of energy production by increased glycolysis and lactic acid fermentation, resembling the Warburg effect observed in cancer cells (Dang, 2010) .
The decrease in ATP in Myc-expressing cells suggested a defect in oxidative phosphorylation. We explored this possibility first using a mitochondrial-localized GFP (MitoGFP) to examine mitochondria in WT and Myc-expressing cells in vivo, in wing discs and in larval fat bodies. Fat body cells are large and flat, facilitating mitochondrial visualization. Both WT wing disc and fat body cells have long, filamentous, perinuclear networks of mitochondria (Figure 1Ha , Figure S2Aa ). Expression of Myc in either cell type increased mitochondrial number compared to WT cells, consistent with Myc's regulation of mitochondrial biogenesis (Figure 1Hb , Figure S2Ab ) . This was confirmed by an increase in citrate synthase (CS) activity, a measure of mitochondrial mass, in Myc cells in culture ( Figure 1I ). Compared to WT cells, Myc-expressing wing disc or fat body cells had few filamentous mitochondria but many small donut shapes and globules (Figure 1Hb, Figure S2Ab) . Mitochondrial morphology is controlled by metabolism (Rossignol et al., 2004; Youle and van der Bliek, 2012) ; thus this remodeling is likely due to altered metabolism in Myc cells.
To evaluate mitochondrial respiration in WT and Myc cells, we quantified ETC function by measuring the activities of ETC complexes. Complex activities were normalized to CS activity to account for mitochondrial number. The activities of complexes I + III (NADH cytochrome c reductase) were similar, and II + III (succinate-cytochrome c reductase) were slightly higher in Myc cells compared to WT ( Figure 1G ). The increase in complex II activity is consistent with higher sdh mRNA expression in Myc cells. However, complex IV (cytochrome c oxidase, COX) activity was significantly decreased in Myc cells (Figure 1G) . Confirming these data, histochemical assays of Sdh (complex II) and COX indicated that Sdh activity was equivalent in both WT cells and Myc cells, but COX activity was reduced specifically in the Myc cells ( Figure S1E ; data not shown).
p53 Buffers Myc-Dependent Glycolytic Flux and Promotes Oxidative Respiration Scox is the sole Drosophila homolog of the mammalian synthesis of Cytochrome c Oxidase 2 (SCO2) (Porcelli et al., 2010) , which is regulated by p53, a critical sensor of cellular stresses including DNA damage and oncogene deregulation (Sutcliffe and Brehm, 2004) . p53 promotes mitochondrial respiration by positively regulating Sco2 and inhibiting glycolysis (Matoba et al., 2006; Vousden and Ryan, 2009 ). Because scox expression was increased in Myc-expressing cells, we investigated the role of p53 in metabolic homeostasis. The D. melanogaster genome contains one p53 homolog (Marcel et al., 2011) that is transcriptionally upregulated in response to tissue and DNA damage (Brodsky et al., 2004; Wells and Johnston, 2012; Wells et al., 2006) . p53 expression is low in WT wing discs (Wells and Johnston, 2012 ) but was induced in cells expressing Myc (Figures 2A  and 2B ) (Hulf et al., 2005; Montero et al., 2008) , as was a p53 activity reporter ( Figure 2C ) (Brodsky et al., 2000) . In cell culture, p53 mRNA was induced 2.5-fold by Myc expression ( Figure S1D ).
To determine if Drosophila p53 functioned homeostatically to counteract the Myc-induced increase in glycolytic flux, we treated WT or Myc cells with p53 dsRNA. Indeed, this significantly reduced scox expression and steady-state ATP relative to controls (Figures 2D and 2E ; data not shown). ETC activity was uniformly reduced, affirming a role for p53 in oxidative phosphorylation (ox-phos) ( Figure 2H ). Using MitoGFP in vivo, we saw disrupted mitochondrial morphology in p53 mutant wing disc cells or fat body cells with a variety of shapes including globules and donut shapes as well as the long filaments that predominated in WT cells (Figure 2Fa , Figure S2Ac ). The increase in mitochondrial number induced by Myc remained in p53 mutants (Figure 2Fb , Figure S2Ad ). Consistent with this, CS activity in Myc cells treated with p53 dsRNA in culture was similar to controls ( Figure 2G ). Thus, despite morphological changes, mitochondrial mass remained the same. In contrast, p53 dsRNA stimulated expression of glut1, glut3, and ldh mRNAs and increased glucose consumption (Figures 2D and 2I) and intracellular lactate ( Figure 2J ) in WT cells and in Myc cells. Thus although virtually undetectable in steady-state conditions ( Figure 2A ), p53 is a physiological regulator of metabolic homeostasis in Drosophila and restrains glycolysis while promoting ox-phos. Moreover, our results suggest that the increase in sdh and scox mRNAs and CS activity in Myc cells compensates for a COX deficiency and reduced ATP. Figure 1D ). Competition also enhanced glycolytic gene expression in Myc cells. Naive WT or naive Myc cells treated with CM from competitive cocultures (cCM) enhanced the increase in glut1 and glut3 mRNA expression in Myc cells ( Figure 3A ). hexokinase C (HK-C) and tpi mRNA were also enhanced by competition ( Figure 3A ), but impl3/ldh mRNA was not. In vivo, uptake of the fluorescent glucose derivative, 2-NBDG (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-D-glucose), was modest in control wing disc cells ( Figure 3B ) but prominently elevated in competing clones of Myc-expressing cells (Figure 3C) , indicating glucose metabolism was also increased during competition in wing discs.
Cell Competition Enhances Myc-Induced Metabolic Flux
Expression of pdh, sdh, and scox mRNA was enhanced by cCM in naive Myc cells ( Figure 3A) as well, but steady-state ATP was not improved. Rather, competition further reduced ATP to only 44% of controls ( Figure 3H , Ctl). Competitioninduced enhanced glycolysis and reduced ATP were specific to Myc cells, as lactate and ATP in WT loser cells remained identical to WT cell in noncompetitive monocultures (Figures 3G and 3H, compare to Figure 1E ). Competition mildly altered ETC activity in Myc cells, and COX activity was further reduced compared to monoculture controls ( Figure 3I ). Thus, confrontation between Myc and WT cells converts Myc cells into supercompetitors and intensifies their already altered metabolism. The significant reduction in steady-state ATP in Myc supercompetitors suggests glycolysis predominates over ox-phos as an energy source.
Enhanced Metabolic Flux in Myc Supercompetitors Requires p53
To determine if p53 functions in Myc supercompetition, we examined cells treated with p53 dsRNA. In competitive cocultures, p53 dsRNA reduced scox mRNA and steady-state ATP even further in Myc cells ( Figures 3E and 3H) . Unexpectedly, glycolytic flux was reduced by p53 dsRNA in Myc supercompetitors, rather than stimulated ( Figures 3E-3G ). Competitioninduced enhancement of glucose consumption and of glut1 and glut3 expression was abolished by p53 dsRNA (Figures 3E and 3F) . Enhanced expression of scox also required p53, indicating that its increase could be triggered in response to reduced ATP. Interestingly, expression of these genes remained higher than in WT cells ( Figure 1B) ; thus glycolytic changes induced by a simple increase in Myc expression are p53 independent. p53 dsRNA did not alter impl3/ldh expression but reduced lactate in Myc cells, and did not affect Myc expression itself ( Figure 3G ). In contrast to Myc supercompetitor cells, WT cells from the same cocultures increased glucose consumption (Figure 3F ) and lactate production ( Figure 3G ) in response to p53 dsRNA, as expected ( Figures 2I and 2J ). In p53 mutant wing discs, Myc-induced 2-NBDG uptake remained high in the absence of competition (i.e., EnGal4>Myc; data not shown) but was noticeably diminished in clones of Myc supercompetitor cells ( Figure 3D ). Thus, p53 is required to enhance the Myc-stimulated increase in metabolic flux. This role is specific to Myc cells in a competitive context and distinct from p53's normal homeostatic function in metabolic regulation.
Enhanced Metabolism Supports Rapid Expansion of Myc Supercompetitor Cells
Since CM from competing cocultures contains a diffusible activity that accelerates proliferation of naive Myc cells relative to controls (Figure 4A, Figures S3B and S3C) (Senoo-Matsuda and Johnston, 2007) , we tested if it required p53-dependent enhanced metabolic reprogramming. We used CM generated from p53-depleted competitive cocultures to treat naive assay cells also pretreated with p53 dsRNA. Indeed, cCM from p53-depleted cocultures was unable to accelerate proliferation of naive Myc cells, whereas ncCM from p53-depleted control cocultures did not alter proliferation of these cells ( Figure 4A ).
The lack of proliferation-stimulating activity in cCM from p53-depleted cocultures could be due to loss of p53's metabolic functions, or to another role of p53. To distinguish between these possibilities we directly disrupted metabolism by treating competitive co-cultures and naive assay cells with dsRNA against glut1, cytochrome-c-d (cyt-c-d), or debcl/drob-1, a Bcl-2 family protein involved in mitochondrial respiration (Senoo-Matsuda et al., 2005) . Like p53 dsRNA ( Figures 2E and  3H) , cyt-c-d or debcl dsRNA leads to reduced cellular ATP (N.S.-M., unpublished data) (Senoo-Matsuda et al., 2005) . cCM generated from these cocultures did not stimulate proliferation of the naive Myc assay cells ( Figure 4C, Figures S3F and S3G) . Knockdown of these genes does not compromise growth of Myc cells or WT cells per se, as ncCM from cyt-c-d or debcldepleted cocultures had little effect ( Figures S3D and S3E) . Thus, treatments that disrupt metabolism in Myc supercompetitor cells suppress the proliferation-stimulating activity in cCM. As the activity is only present in cCM, and since Myc cells, but not WT cells, respond to it, these results suggest that p53-mediated enhanced metabolism promotes accelerated proliferation of Myc supercompetitor cells in culture.
A second activity in cCM causes naive WT cells to proliferate slower in response to cCM due to increased apoptosis (Figure 4B ) (Senoo-Matsuda and Johnston, 2007) . However, cCM from p53-depleted cocultures stimulated faster proliferation of naive WT cells ( Figure 4B ). This correlated with increased glut1, glut3, and scox expression and higher glucose consumption, as expected after p53-depletion ( Figure 3F ; data not shown). Thus, whereas p53 loss dampens glycolysis in Myc supercompetitor cells, it stimulates it in WT loser cells, indicating that p53 function in Myc cells in a competitive context is qualitatively different from its homeostatic role in regulation of metabolism. cCM from glut1, cyt-c-d, or debcl-depleted cocultures was still as effective as control cCM at reducing the proliferation of naive WT cells ( Figure 4D , Figure S3G ), due to a similar frequency of apoptosis (data not shown). The supercompetitor killing activity is thus lost in p53-deficient cCM, but is retained in cCM from metabolically disabled cocultures. Thus p53-mediated enhanced metabolism in Myc cells promotes supercompetitor status but cannot explain every aspect of the behavior. During rapid growth, glutamine pools can be limiting for macromolecular biosynthesis, and its uptake is increased in some cancer cells (DeBerardinis et al., 2007; Yuneva et al., 2012) . We found increased expression of the glutamine synthases GS1 and GS2 and an uncharacterized gene encoding a glutaminase (CG42708) in Myc cells compared to WT cells that was enhanced in Myc supercompetitors ( Figure S4A ). To determine if glutamine uptake was altered in Myc supercompetitors, we compared glutamine consumption in noncompetitive versus competitive conditions in WT and Myc cells. Unexpectedly, monocultures of Myc cells consumed less glutamine than WT cells ( Figure S4A ). Glutamine consumption slightly increased in naive Myc cells grown in cCM but remained less than naive WT cells in cCM ( Figure S4A) . Thus, glutamine utilization may play a role in Myc cells, but its uptake is not rate limiting for rapid expansion of Myc supercompetitor cells.
Expansion of Myc Cell Populations Requires p53 Only during Competition
Our experiments indicate that without p53, WT ''loser'' cells became ''winners'' and proliferated more, seemingly reversing the outcome of competition. To determine if p53 loss in vivo had the same effect, we induced clones of loser cells in p53 mutant wing discs using a competition assay in which all cells express Myc constitutively at a moderate level via a tub > myc > Gal4 gene cassette (''>'' denotes FRT site) (de la Cova et al., 2004; Wu and Johnston, 2010) . ''Flp-out'' of the > myc > cassette generates cell clones expressing UAS-GFP (loser GFP clones); these cells are WT with respect to Myc but are disadvantaged because they are surrounded by tub > myc > Gal4 cells (de la Cova et al., 2004) . WT loser GFP clones grew significantly slower than control GFP clones ( Figures 5A and 5C ). However, in either of two p53 null mutants, loser GFP clones grew to much larger sizes (Fig- ures 5B and 5C; data not shown), growing as well as control clones not subject to competition ( Figure 5C ). Consistent with our cell culture experiments, Myc-expressing cell clones generated in p53 mutant wing discs grew slower than controls ( Figure S6C ). Control GFP clones generated in either WT or p53 mutant backgrounds grew at similar rates ( Figure S6C) ; thus loss of p53 selectively prevents expansion of competing Myc clones. Thus, in the absence of p53, Myc supercompetitor cells are unable to expand, while loser cells resist competition and survive.
Expansion of the Myc population requires increased ribosome biogenesis and activity, a signature of Myc activity manifested in wing discs by increased cell and nucleolar size, and correlates with increased expression of the nucleolar protein, Fibrillarin (Fib) (Grewal et al., 2005; Johnston et al., 1999) . We used these criteria to test if p53 was required for Myc to regulate ribosomal activity. Fib expression, nucleolar size, and cell size in Mycexpressing clones were unaffected in p53 null mutants ( Figures  S4B-S4D) . We conclude that although it is required for Myc's supercompetitor metabolism and for expansion of the Myc supercompetitor population, p53 is not required for Myc to stimulate cellular growth. (Morata and Ripoll, 1975; Simpson, 1979) . In M(3) RpS3/+ mosaics, clones of WT cells compete to occupy the wing disc and, when examined after short defined time periods, grew significantly faster than WT clones in WT discs ( Figure S5A) ; these findings differ from a previous report (Martín et al., 2009 ). To test whether p53 mutant cells also ''win'' in competition with M(3)RpS3/+ cells, we generated p53 mutant clones in M(3)RpS3/+ wing discs. The clones grew faster than control p53 clones in p53 mutant wing discs and still populated a large fraction of the mature wing disc. However, the rate of p53 mutant ''winner'' cell proliferation was 25% slower than WT counterparts over the same time period ( Figure S5A ). We conclude that although p53 loss does not abolish competition with M(3) RpS3/+ cells, it compromises the accelerated proliferation of winner cells.
In a second test, we examined competition between WT cells and dm mutant cells. As shown previously (Neto-Silva et al., 2010; Wu and Johnston, 2010) , WT cells near dm mutant cells gained winner status and proliferated at a faster rate than when in a milieu of other WT cells ( Figure S5B, left) . In either a hypomorphic dm P0 mutant or a null mutant dm 4 background, this was prevented by p53 loss ( Figure S5B , right). Still, a p53 mutant background did not completely abolish competition, as dm mutant clones remained small. However, in three independent competitive contexts-Myc supercompetitor versus WT cells, WT cells versus M/+ cells, and WT cells versus dm mutant cells-p53 is an important mediator of the rate at which the winner cell population expands, and therefore of the cell population's fitness.
p53 Is Selectively Required in Myc Supercompetitors for Genome Stability, Survival, and Competitiveness WT loser cells are eliminated from wing discs due to induction of the proapoptotic factor Hid (de la Cova et al., 2004) . The number of loser cells expressing the active-caspase 3 (C3) apoptotic marker increases soon after induction of competition in tub > myc > Gal4 discs in either WT or p53 mutant backgrounds ( Figures 5D-5F , GFP[+]; Figures S6A and S6B ). However, within 24 hr after induction in p53 mutant wing discs, we observed three times more C3-positive Myc supercompetitor cells than were present in a WT background ( Figures 5D-5F , GFP [À] ). Many C3 (+) p53 mutant, Myc supercompetitor cells were close to GFP loser clones ( Figures 5E and 5G ). In addition, many p53 mutant Myc supercompetitor cells expressed the DNA damage marker, g-H2AX, whereas in GFP loser cells g-H2AX was rare (Figures 5Gi-5Giii ). These findings and the fact that few competing Myc cells die in WT wing discs prompted a series of additional controls to rule out trivial causes of cell death. When all cells in p53 mutant wing discs expressed extra Myc via an intact tub > myc > Gal4 cassette (a noncompetitive environment), cell death was comparable to that in WT controls (data not shown). The heat shock treatment used to induce clones also did not increase C3-or g-H2AX-positive tub > myc > Gal4 cells ( Figure 5H ). Notably, C3 and g-H2AX marks did not always correlate, suggesting g-H2AX was not due to caspase activation (Rogakou et al., 2000) . Finally, neutral GFP clones generated in p53 mutant discs did not die more frequently than in WT discs ( Figures S6C and S6D) ; similar results were obtained in the S2 cell competition assay (Figure S6E) . Thus, although p53 mutant, tub > myc > Gal4 cells survive and proliferate normally in wing discs for several days prior to stimulation of competition, within 24 hr of induction of GFP loser clones, genome destabilization in Myc cells leads to the appearance of g-H2AX and to increased apoptosis. Accordingly, p53 selectively promotes the viability and genomic integrity of Myc supercompetitors. Without p53, the death of Myc winner cells prevents their expansion as a population, and the WT losers gain the advantage. This altered outcome could be due to a requirement for p53 in either population. To determine which cells autonomously require p53 function, we created p53 null FRT chromosomes wherein the mutation was either linked or unlinked to the Gal4 inhibitor, Gal80. This allowed us to separately assess the contribution of p53 to Gal4-regulated Myc cell clones and to their WT sibling cell clones, both produced by one mitotic recombination event ( Figure 6 ) (de la Cova et al., 2004; Lee and Luo, 2001) . Consistent with our previous findings, Myc clones grew faster than GFP controls at the expense of their WT sibling clones (Figures 6B and 6E) . p53 loss specifically in loser clones (siblings of Myc supercompetitor clones) did not alter their own growth or that of the Myc clones ( Figures 6A-6C ). However, Myc clone size was reduced 40% by loss of p53 ( Figure 6D ), to smaller than WT control clones ( Figures 6E and 6F) . p53 mutant Myc clones were also no longer competitive, allowing WT sibling clones to grow as well as their counterparts in controls ( Figures  6E-6G ). p53 is thus specifically and cell-autonomously required in Myc supercompetitor cells.
The ability of loser cells to survive when Myc supercompetitors lack p53 suggested the latter had lost their killing activity. Whether this activity required cell survival-for example, for efficient signal transmission to loser cells-remained unclear. If survival and competitiveness are coupled, blocking death of p53 mutant Myc supercompetitors might allow them to be competitive. We therefore protected p53 mutant Myc cells from death with the caspase inhibitor, P35 (Hay et al., 1994) , and measured the size of these clones and their WT sibling clones after a defined period of growth. Expression of P35 in either WT or p53 mutant cell clones did not affect clonal growth in controls ( Figures 6H and 6J) , and coexpression of Myc and P35 did not block supercompetitor status, since their sibling clones were smaller than controls ( Figure 6J ). Preventing apoptosis allowed p53 mutant, Myc-expressing clones to grow to the same size, and at the same rate, as WT Myc supercompetitor clones ( Figure 6K versus Figure 6J) . Thus, the inability of the p53 mutant Myc supercompetitor population to expand is due to cell death that requires the presence of nearby WT cells. Despite rescue of Myc clone size, WT sibling clones were equal in size to sibling clones in noncompetitive controls ( Figure 6K) ; thus, without p53, Myc cells do not transmit a killing signal to their WT neighbors. Collectively, our results demonstrate that Myc 
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Myc Supercompetition Requires p53 supercompetitor cells require p53 cell-autonomously for survival and supercompetitor status.
DISCUSSION
We have addressed the basis of cell fitness during Myc-induced supercompetition, a paradigm of cell competition with parallels to mammalian tumor promotion. Here we extend these parallels with our finding that in Drosophila cells, extra Myc activity biases cells to glycolysis and lactic acid fermentation for energy production, as c-Myc does in many cancers (Dang, 1999; Shim et al., 1997) . Although they were primarily analyzed in S2 cells, we also observed metabolic changes during competition in wing discs that suggest metabolism is similarly altered in vivo during competition. Intriguingly, our work reveals that increased Myc alters mitochondrial morphology and impairs complex IV (COX) activity, thereby weakening the ETC, which presumably causes the reduced cellular ATP in Myc cells. Together, the compromised ETC and rise in glycolysis in Myc cells echoes Warburg's observation of flawed mitochondria and increased fermentation in cancers (Warburg, 1956) . Increased glycolysis can benefit cells by freeing them from reliance on the slow but efficient energy production by ox-phos (Pfeiffer et al., 2001; Ristow and Shulz, 2009) . Our finding raises the question of whether the glycolytic increase in Myc cells is independent of a faulty ETC, or is induced to compensate for defective complex IV activity and low ATP.
Our results also establish evolutionary conservation of p53's homeostatic role in metabolic regulation in proliferating Drosophila cells (Cheung and Vousden, 2010; Matoba et al., 2006) . Moreover, p53 balances internal metabolic changes in Myc cells by promoting ox-phos and curbing glycolysis. That the COX deficiency and low steady-state ATP are accompanied by a p53-dependent increase in scox mRNA suggests p53 is induced in Myc cells in a homeostatic response to protect fitness. As p53 is a sensor of numerous cellular stresses, we postulate that its activity increases in Myc cells to balance their metabolism ( Figure 7A) . The relationship between Myc and p53 could feasibly function as a conserved module for adaptation of cells to metabolic perturbation.
In striking contrast to Myc cells on their own, when Myc cells coexist with WT cells in mixed populations they undergo several additional p53-dependent changes: they produce (and also resist) a diffusible killing factor, they gain an increase in reproductive potential, and glycolytic flux is considerably enhanced. Notably, these events happen within hours (de la Cova et al., 2004; Senoo-Matsuda and Johnston, 2007) . The diverse p53-dependent changes in Myc cells imply that p53, already active to balance metabolism, detects confrontation with WT cells via a distinct role, initiating a new program that converts Myc cells into supercompetitors. Enhanced glycolytic flux is clearly part of this program, but given that p53 normally suppresses glycolysis, we speculate that it is only indirectly regulated by p53. Even so, without p53, Myc supercompetitors completely lose the traits distinguishing them from Myc cells in a homotypic environment, suggesting that p53 is a sensor of confrontation between the two populations; in its absence the cells do not ''recognize'' their differences.
Supercompetitor status (and winner status in general) is an acquired property of cells, dictated by their local environment. Activation of Jun N-terminal kinase signaling in competing cell populations indicates that the confrontation is stressful (de la Cova et al., 2004; Moreno and Basler, 2004) , which could elicit additional p53 functions. If so, the degree of p53 activation may be a proxy for the level of stress the cells receive. Thus, Myc cells lacking p53 are viable in a homotypic setting despite acute metabolic changes, but the additional stress of a heterotypic milieu leads to inviability. p53 function in Myc cells is context dependent: it is first activated to balance metabolic distress induced by Myc, and second, confrontation with WT cells activates a different function of p53 that leads to a program providing the supercompetitor phenotype. Given the rapid induction of supercompetitor behavior, we speculate that posttranslational mechanisms are involved.
How is confrontation sensed by p53? With the exception of the killing activity, the supercompetitor phenotype is an exaggeration of existing properties of Myc cells. That heterotypic confrontation causes a significant rise in metabolic flux in Myc cells raises the possibility that metabolites play a role. Like p53 depletion, direct metabolic disruption limits the fitness increase of Myc supercompetitors, revealing an important metabolic underpinning to their status. However, direct metabolic disruption did not block production of the killing activity, and thus metabolism cannot account for all supercompetitor traits. Although metabolic functions of p53 are required for some supercompetitor behaviors, our results suggest that p53's role in promoting fitness of WT winner cells in other competitive contexts is related to the confrontational response, rather than direct metabolic regulation. Still, the evidence that p53 promotes reproductive fitness of ''winner'' cells in other heterotypic contexts raises the possibility that p53 generally functions as a sensor of genetic heterogeneity. Whether metabolic alterations are sensed or mediate winner behavior in these contexts remains to be seen. 
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Supercompetitor status increases Myc cell fitness but also comes at the cost of life-threatening vulnerability to loss of p53. Although the root cause of the vulnerability is unknown, our results suggest several possibilities. In the absence of p53, confrontation of Myc and WT cells leads to H2AX phosphorylation in Myc cells, thus DNA damage may selectively compromise survival of Myc supercompetitor cells. Myc cells have increased reactive oxygen species (ROS; M.Z., unpublished data), possibly arising from enhanced metabolic flux, which can cause genomic damage (Greer et al., 2013; K et al., 2006) . As p53 has antioxidant functions (Budanov et al., 2004; Sablina et al., 2003) , its loss in Myc supercompetitors could intensify ROS and increase genomic instability. In addition, confrontational stress coupled with loss of p53's ox-phos-promoting capacity could lead ATP to fall below a critical threshold in the Myc cells. However, when protected from apoptosis, p53 mutant Myc supercompetitors proliferate with the same kinetics and to the same extent as WT Myc supercompetitors. Thus Myc remains fully functional as a growth regulator in p53 mutant cells and also still stimulates glycolytic flux.
Regardless of the mechanism, the phenotypic differences between Mycexpressing cells and Myc-supercompetitor cells provide a clear demonstration of the determinative nature of cellular context, a hallmark of cell competition. Given the conserved metabolic functions of Myc and p53 we document here and the frequent activation of Myc family proteins in cancer, our findings predict that homeostatic p53 activity is induced to balance the glycolytic shift in incipient cancer cells. Moreover, in normal tissues, confrontation with an emerging patch of such precancerous cells could encourage tumor growth and fitness by promoting the cells' acquisition of supercompetitor status. In this regard, the apparent cooperative relationship between Myc and p53 in regulating supercompetition is particularly disquieting in terms of cancer. Two points are worth considering further. First, cancer cells commonly take advantage of glycolysis to fuel rapid energy production, but this is thought to evolve over time in response to constraints on growth (such as oxygen availability) as the tumor cells become invasive (Gatenby and Gillies, 2004) . Myc-expressing cells acquire supercompetitor status within a few hours of confrontation with WT cells (Senoo-Matsuda and Johnston, 2007) , immediately giving them a competitive advantage, suggesting that selective pressure is not necessary for precancerous cells to acquire a metabolic profile associated with supercompetitor behavior. Second, although TP53 mutations are among the most frequent in cancer, their tumor-promoting effects are only evident over relatively long timescales, and additional mutations are important for malignancy (Ziegler et al., 1994) . We suggest that, like Myc supercompetitor cells, precancerous cells arising among otherwise healthy cells may initially require p53 for their survival. Time and sensitivity to additional stresses could facilitate p53 loss, after which continued tumor growth would be predicted to occur only in cells successful at adapting to its loss, an idea supported by recent work in human cells (Maddocks et al., 2013) . Thus our finding that p53 is critically important for the survival of supercompetitor cells could be relevant when considering therapies in early stages of tumor promotion.
EXPERIMENTAL PROCEDURES
Somatic Clones
The tub > myc > Gal4 cassette was used to generate random GFP-marked tub > Gal4 clones (de la Cova et al., 2004) . Tub > Gal4 clones were induced by heat shock (HS) of larvae at 37 C for 25 min at 48 hr after egg laying (AEL), and animals were allowed to grow until the indicated time point. The act > y, stop > Gal4 cassette was used to generate random GFP or Mycexpressing act > Gal4 clones in WT wing discs. Act > Gal4 clones were induced by larval HS at 37 C for 15 min at 48 hr AEL and animals treated as above. For p53 mutant clones we tested two null alleles, p53 ns and p53 5-a-1-4 , which behaved similarly.
Clonal Growth Measurements
Clonal growth was determined by measuring the two-dimensional area of clones (mm 2 ). Clone size measurements were made using a Zeiss Axioplan 2 microscope with an Orca-100 CCD camera (Hammatsu). Clone area was measured at 2003 magnification using Axiovision 4.6 software.
Histology
Fixation, antibodies and staining of imaginal discs, and RNA in situ hybridizations with digoxigenin-labeled RNA probes were done as described (de la Cova et al., 2004) . Images were acquired with Axiovision 4.6 or Leica SP5 confocal system software. See the Supplemental Information for details.
Cell Culture Assays WT cells and Myc cells were plated for monoculture, direct coculture, or indirect coculture at equal density and incubated 16 hr, after which medium was replaced with medium ±125 mM CuSO 4 (Senoo-Matsuda and Johnston, 2007) . Culture systems, C3 activity measurements, and growth assays were as in Senoo-Matsuda and Johnston (2007) .
ATP, Lactate, and Pyruvate Assays WT cells and Myc cells were treated ced-9 (control) dsRNA or p53 dsRNA in the absence of CuSO 4 for 96 hr and then plated for monoculture or indirect coculture for 16 hr (Senoo-Matsuda and Johnston, 2007) . Cells were then treated ±125 mM CuSO 4 for 24 hr. For ATP analysis, the cells were lysed in Reporter Lysis Buffer (Promega) and lysate used in the ATP Determination Kit (Invitrogen). Lactate and Pyruvate Assay Kits (BioVision) were used as per manufacturers' instructions.
Glucose Consumption and 2-NBDG Assays CM was collected from single, indirect, or direct cocultures of WT and Myc cells and glucose assessed using the Glucose (GO) Assay Kit (Sigma). For in vivo assessment of glucose uptake, wing imaginal discs were monitored as follows: control RFP or RFP + Myc-expressing clones were induced at 48 hr AEL and larvae dissected at 96 hr AEL. Dissected larvae were incubated in PBS with 0.25 mM 2-NBDG (Invitrogen) for 45 min at 25 C, washed twice in PBS for 10 min, fixed 20 min in PBS + 4% PFA, and washed again twice for 10 min in PBS. All washes and the fixation were done with precooled PBS (4 C). Imaginal discs were stained with Hoechst, rapidly dissected, and mounted in Vectashield, and images were immediately collected with a Leica SP5 confocal microscope. 2-NBDG fluorescence was excited at 488 nm and detected at 500-520 nm. RFP fluorescence was excited at 543 nm and emission detected at 550-645 nm (Zou et al., 2005) .
Quantitative RT-PCR WT or Myc cells were collected from monocultures or indirect cocultures for analysis after 24 hr of the appropriate treatment. Reverse transcription (RT) to produce single-stranded cDNA was performed using 0.5-1 mg total RNA and SuperScript First-Strand Synthesis kit (Invitrogen). RT plus and minus controls were done in parallel. Q-PCR reactions were performed using LightCycler FastStart DNA MasterPlus SYBR Green I kit (Roche). Standard curves were produced using serially diluted cDNA made from WT cells for each primer set. Amplification was done using standard conditions in a Roche LightCycler. act5C mRNA was used to normalize data. Primer sequences are listed in Table S1 .
dsRNA Treatment WT or Myc cells were pretreated with dsRNA against ced-9 or gfp (used as controls), p53, glut1, cyt-c-d, or debcl for 72-96 hr as described (SenooMatsuda and Johnston, 2007) . See the Supplemental Information for details.
Mitochondrial Respiratory Chain Complex Activities
Complex activities were measured according to DiMauro et al. (1987) . See the Supplemental Information for details.
Statistics
All values are means of R3 independent experiments. Student's t test was used to determine significance (two-tailed, unequal variance). p values are as follows: * p < 0.05,** p < 0.01, *** p < 0.001. All error bars are standard deviation (SD) unless otherwise indicated in the figure legend. 
